Longsworth Todd Christopher
- SEC CIK
- 0001693530
No open-market purchases or sales filed in the past year.
Current role at each company
- NVCR NovoCure LtdGeneral Counselas of Mar 9, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Longsworth Todd Christopher as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 9, 2022 (view filing) | Mar 8 | 1 day | Longsworth Todd ChristopherGeneral Counsel | SSale | −2.34K | $70.10 | −$164.0K | −3.6%62.5K after | |
| Mar 7, 2022 (view filing) | Mar 3-4 | 4 days | Longsworth Todd ChristopherGeneral Counsel | SSale | −3.07K | $71.87 | −$220.4K | −4.5%64.8K after | 2 lots |